Health Insurance (Section 3C General Medical Services – Menopause and Perimenopause Health Assessment Services) Determination 2025

The Determination uses a short set of interlocking legal concepts drawn from the Health Insurance Act framework and the general medical services table. Understand these concepts as the building blocks that determine legal status, claimability, practitioner scope and temporal limits.

Relevant service and clinically relevant service. The instrument operates by defining a "relevant service" as a health service specified in a Schedule (s 4 Definitions) and then treating that relevant service, when provided in accordance with the Determination and as a clinically relevant service, as if it were a professional and medical service with an associated item in the general medical services table (s 5). The Determination relies on the external definition of "clinically relevant service", which the note in s 4 records is defined in subsection 3(1) of the Act. The Determination therefore reaches into the Act's existing schema for what counts as claimable medical work.

Importation of item status. Section 5 is the mechanical conversion: it instructs that for the relevant provisions these services are to be treated as if an item existed in the general medical services table that relates to the service and specifies a fee in relation to each State, the fee being that in the Schedule. The operative mechanism is not to amend the general medical services table itself, but to treat the services as if an item were in that table for the purposes of the "relevant provisions" named in s 4. This means that whatever legal consequences flow from being an item in the general medical services table will apply to these services, subject to the particular subclauses the Determination imports (s 6).

Imported application of particular subclauses. Section 6 expressly binds the services to clause 2.15.1 and clause 2.15.14 of the general medical services table by specifying that those clauses shall have effect as if items 695 or 19000 were contained in the relevant subclauses. The Determination does not restate clause text; it creates a statutory bridge so that the operational rules inside those clause numbers apply to these items.

Eligibility and frequency control. Section 7 sets two substantive eligibility controls. First, the service must be provided to a patient experiencing one or more specified symptoms or undergoing treatment for them (premature ovarian insufficiency, early menopause, perimenopause, menopause). Second, it is limited by a 12-month frequency rule: a patient must not have received either of these services in the preceding 12 months. The Determination therefore defines the clinical target population and a periodicity constraint.

Clinical content and minimum duration. The Schedule describes the required content and sets a minimum duration of 20 minutes for the professional attendance. The listed elements are history-taking to determine menopausal status and contraindications, a basic physical (blood pressure, height and weight), initiating investigations/referrals where clinically indicated, discussion of management options (non-pharmacological and pharmacological, risks and benefits), implementation of a patient-centred management plan, and provision of preventative health advice including physical activity, smoking cessation, alcohol, nutrition and weight management. The written description uses "including, but not limited to", indicating a non-exhaustive list.

Fee setting and differential rates. The Schedule fixes fees for each item and differentiates by practitioner type: item 695 (general practitioner) at $101.90 and item 19000 (prescribed medical practitioner) at $81.50. The instrument thereby sets a monetary parameter that applies across States for those items.

Temporal scope. The Determination is temporary: commencement 1 July 2025 (s 2) and repeal 30 June 2027 (s 8). Section 4 also confirms that references to provisions of the Act and the National Health Act are to be read as in force from time to time, meaning that the legal environment this Determination references can change over the two-year term and affect operation.

Interactions with other instruments. Section 9 explains that each instrument specified in a Schedule is amended or repealed as set out in the applicable items in the Schedule, and any other Schedule item has effect according to its terms. In practice the Schedule here lists the items rather than amendments to other instruments, but the drafting preserves the mechanism to amend existing instruments where specified.

Authority. The Determination is made under s 3C(1) of the Health Insurance Act (s 3 Authority), so its legal power flows from ministerial authority conferred by that provision. The schedule and clause references point practitioners and payers back to the general medical services table and the Act for the detailed claim conditions.

The Determination touches multiple categories of actors because it redefines how particular clinical encounters are to be treated under the Health Insurance Act framework and attaches fee values. The principal affected actors are clinicians who may provide the listed service, patients presenting with menopausal symptoms, claim processors and payers governed by the relevant provisions, practice administrators and billing software vendors, and policy advisers monitoring time-limited measures.

Clinicians. The Schedule distinguishes between a "general practitioner" delivering item 695 and a "prescribed medical practitioner" delivering item 19000. The descriptions require at least 20 minutes of professional attendance and a set of clinical activities. Any clinician who provides the listed described activities to an eligible patient will need to identify which item number applies and satisfy the imported claiming rules (s 5 and s 6). The Determination therefore affects scope of practice decisions, billing classifications and documentation practice for those clinicians.

Patients with menopausal symptoms. Section 7 limits the service to patients experiencing one or more symptoms of premature ovarian insufficiency, early menopause, perimenopause or menopause, or undergoing treatment for those symptoms. Patients seeking an assessment outside those clinical parameters are not eligible under this Determination. Additionally, a patient who has already received "either of these services" within the previous 12 months is excluded, so patient eligibility is subject to a frequency control.

Billing bodies and payers. The Determination treats the services as if they were items in the general medical services table for the "relevant provisions" (s 5), and makes clause-level linkages in s 6. Entities that administer benefits under the Act are therefore affected because they must apply the relevant provisions and the imported clause rules when processing claims for these items. The Determination sets fee amounts in Schedule 1; processing systems must be updated to reflect item numbers and fees for claims made on or after 1 July 2025 (s 2).

Practice administrators and billing systems. The instrument requires procedural changes: medical practices must ensure consultations meet the 20-minute minimum; record the elements set out in the Schedule if they are to consider the attendance a Menopause and Perimenopause Health Assessment; and apply the 12-month rule. Billing software vendors and practice administrators must map item 695 and item 19000 to the correct internal codes and apply the fee values $101.90 and $81.50 respectively.

Referrers and diagnostic services. The Schedule anticipates initiating investigations and referrals as clinically indicated, including consideration of cervical screening, mammography and bone densitometry. Diagnostic services and specialist clinics therefore may see referrals that reference the Determination-based assessment item. The Determination does not control the availability or funding of the downstream tests, but it defines the assessment context in which clinicians are to consider those investigations.

Regulatory and policy actors. Because the instrument is temporary (repealed 30 June 2027) and explicitly treats references to the Act and National Health Act as being to those provisions "as in force from time to time" (s 4), policy units, regulators and compliance functions must track any intervening changes to the Act, the general medical services table and related regulations during the two-year period.

Legal advisers. Issues of item eligibility, practitioner classification, the meaning of "either of these services" in s 7, and the application of clauses 2.15.1 and 2.15.14 of the general medical services table will present interpretive questions. Lawyers advising clinicians, administrators or payers will need to reconcile the Determination text with the general medical services table provisions it imports.

Absent explicit statements in the Determination about who pays directly, the instrument nonetheless sets out fees and imports item status; who ultimately bears the cost in practice will follow from the "relevant provisions" in the Act and from funding and billing arrangements that those provisions prescribe.

The Determination imposes specific duties on clinicians who intend to claim for the two listed services, and it creates enforceable legal rights in the sense that the services are to be treated as if items in the general medical services table for the relevant provisions, with specified fees.

Duty to meet the service description and minimum duration. Both item descriptions require a professional attendance of at least 20 minutes and a set of clinical actions: history-taking to determine pre-, peri- or post-menopausal status and contraindications, a basic physical exam including blood pressure and review of height and weight, initiation of investigations and referrals as clinically indicated (with consideration of cervical screening, mammography and bone densitometry), discussion of management options including risks and benefits, implementation of a patient-centred management plan, and provision of preventative health care advice (Schedule 1). The duty for the clinician is to perform the attendance in accordance with that description if they are to rely on the item.

Duty to apply eligibility and frequency control. Section 7 creates a duty to ensure that the patient is experiencing one or more relevant symptoms or undergoing treatment for those symptoms, and to ensure the patient has not received either item within the previous 12 months. Clinicians and claimants must therefore check patient history and previous claims to ensure compliance with the 12-month restriction.

Duty to claim under the correct item number. Clause 6 imports particular subclauses of the general medical services table to have effect as if the items were specified in those subclauses. Although the Determination does not restate every claim condition, there is a duty to observe the relevant parts of the general medical services table (clauses 2.15.1 and 2.15.14 as applied by s 6) when making a claim. The Determination therefore creates an expectation that providers will consult the general medical services table for the procedural and substantiation requirements that those clauses impose.

Duty to follow "relevant provisions" as in force. Section 4 states that a reference in this instrument to a provision of the Act or the National Health Act or regulations as applied, adopted or incorporated in relation to specifying a matter is a reference to those provisions "as in force from time to time". Practically, claimants must keep abreast of any changes to the Act, regulations or the general medical services table during the Determination's operative period because those changes can alter the duties attached to providing and claiming the service.

Right to rely on item treatment and fee specification for the period the Determination is in force. Section 5 gives the legal effect that, for the relevant provisions, the relevant service is to be treated as if it were an item with the fee specified in the Schedule. That confers a statutory basis for making claims under the item numbers and attaching the specified fees, subject to all applicable rules. The Schedule specifies fees of $101.90 for item 695 and $81.50 for item 19000, thereby providing a legal reference price for claim processing.

Temporal rights and obligations. The Determination commences on 1 July 2025 and is repealed at the end of 30 June 2027 (s 2 and s 8). The right to treat the described attendance as an item, and the duty to comply with the Determination's terms, exist only during that period. Claims for services that occurred outside the operative dates must be tested against the laws in force for those dates.

Duty to ensure correct practitioner classification. The two items are tied to different practitioner descriptors; the Determination's note on definitions references subsection 3(1) of the Act for the definitions of terms such as "professional service" and "item" (s 4). The duty falls on the practitioner and the practice to ensure the correct practitioner classification is used when claiming the relevant item.

No new penalty provisions stated in the Determination. The instrument does not itself set out penalties for incorrect claims; enforcement and penalty mechanisms will be those contained in the Act and the general medical services table as applied (see s 5 and s 6), and practitioners must be aware that existing claim-related obligations and penalty regimes under the statutory framework continue to apply.

The Determination does not create new penalty mechanisms in its text; rather, it brings the listed services into the existing enforcement and penalty framework that governs items in the general medical services table and claims under the Health Insurance Act. Where the Determination says a relevant service is to be treated "for the relevant provisions" as if it were an item in the general medical services table (s 5), the natural legal consequence is that any enforcement, audit, penalty or recovery processes that apply to items and claims under the Act and the general medical services table will be the mechanisms that govern compliance and enforcement for these items as well.

Imported enforcement mechanisms. Section 6 imports specific clauses of the general medical services table (clause 2.15.1 and clause 2.15.14) to apply to these items. Although the Determination does not reproduce the content of those clauses, the instruction that they "shall have effect" in relation to the items means that any procedural or evidentiary requirements, claim restrictions, or administrative check points that those clauses impose will operate, and any consequences attached to breaches of them will apply. For example, if clause 2.15.1 or 2.15.14 in the general medical services table contains requirements about documentation, patient eligibility, or practitioner qualifications, failure to meet those requirements would attract the general enforcement measures applicable to items under the Act.

Statutory recovery and penalties under the Act. The Determination sits within the Health Insurance Act architecture by virtue of its s 3C(1) authority and its direction to treat services as if items exist in the general medical services table (s 5). Enforcement powers and penalty provisions located in the Act and regulations that apply to dishonest or incorrect claims, false statements, or failures to meet claim conditions will therefore be available to the administering authority to the extent they apply to the items as treated under the Act. The Determination itself does not alter those powers.

Audit and verification risk. Because the items are time-limited, subject-specific and define a minimum consultation period and listed clinical elements, claims for these items are likely to be verifiable by reference to clinical records. Claim processors and auditors applying the relevant provisions will have the basis to verify time spent, recorded clinical activity and prior services to assess the 12-month eligibility rule in s 7. The Determination by specifying a detailed description may therefore increase the ease with which auditors can test whether a claim meets the item description.

No express criminal or disciplinary provisions introduced. The Determination does not introduce criminal offences or professional disciplinary measures; such sanctions, if relevant, are those that exist generally under the Act, the National Health Act, or professional regulatory regimes. Practitioners should therefore assume that ordinary Act-based administrative penalties and recovery mechanisms, together with professional regulation, are the enforcement avenues that will be engaged where a claim is not in accordance with the Determination and the relevant provisions it imports.

Temporal enforcement window. Because the instrument operates only between 1 July 2025 and 30 June 2027 (s 2 and s 8), enforcement actions will relate to services provided and claims made in that period. Any retrospective or forward-looking adjustments will be constrained by the legal regime applicable to that time window and by the Act's ordinary limitation and review processes.

Recommendation for actors. In the absence of new penalty text, clinicians and administrators must consult the Health Insurance Act, the general medical services table (including the specific clauses referenced in s 6), and any administrative guidance published by the relevant agency to understand the detailed compliance and penalty landscape that governs these items.

The Determination explicitly cross-references and imports parts of the Health Insurance Act 1973 framework and the National Health Act 1953 by design, and it creates operative dependencies on provisions and definitions that remain outside the instrument. Understanding the interaction requires attention to the cross-references the Determination itself creates.

Direct statutory interaction. Section 3 states that the instrument is made under subsection 3C(1) of the Health Insurance Act 1973. Section 5 directs that, for the "relevant provisions", the relevant service be treated as if it were both a professional service and a medical service and as if there were an item in the general medical services table specifying a fee in relation to each State. The "relevant provisions" are defined in s 4 to mean "all provisions, of the Act and regulations made under the Act, and the National Health Act 1953 and regulations made under the National Health Act 1953, relating to medical services, professional services or items." Thus, the Determination triggers the full gamut of statutory rules that apply to medical and professional services and items under both Acts to the extent those rules relate to items and services.

Reliance on external definitions. Section 4 notes that several terms used in the Determination are defined in subsection 3(1) of the Health Insurance Act, including "clinically relevant service", "general medical services table", "item" and "professional service". The Determination therefore needs to be read together with those definitions, and any interpretive questions about these terms will be decided by reference to the Act's definitions. The Determination also instructs that references to provisions are to be read as in force from time to time, so any amendments to the Act or the National Health Act during the Determination's operative period will affect the application of the Determination (s 4).

Interaction with the general medical services table. The Determination does not itself alter the general medical services table directly; rather, it creates a legal fiction that the specified items exist in the table for the purposes of the relevant provisions. Section 6 goes further by applying clause-level provisions of the table , clause 2.15.1 and clause 2.15.14 , to these items. Therefore the Determination's operation depends on the content of those clauses in the general medical services table, which remain external to the Determination. Practitioners and payers must therefore consult the general medical services table, and specifically clauses 2.15.1 and 2.15.14, to understand the complete set of operative rules.

Claims and other statutory programmes. The Determination sets item fees in Schedule 1 but does not address payment mechanics, bulk-billing rules, patient co-payments, or interactions with other funding schemes or rebates administered under the National Health Act 1953. However, because the Determination explicitly incorporates the "relevant provisions" of the National Health Act and regulations relating to items and medical services (s 4 and s 5), the practical interaction with other statutory funding and rebate programmes will be determined by those external provisions as in force.

Temporal interaction with future legislation. The Determination is time-limited (s 2 and s 8) and s 4 explicitly provides that references to provisions are to be read as in force from time to time. This means that amendments to the Health Insurance Act, the general medical services table, or to the National Health Act and its regulations during the period 1 July 2025 to 30 June 2027 can change how the Determination operates without further amendment to the Determination itself. The Determination therefore interacts dynamically with the statute book.

Administrative guidance and policy instruments. While the Determination is the legal instrument that sets the item treatment and fees, procedural matters such as how to substantiate claims to an administrative processing body, whether forms or templates are required, and how to demonstrate the 20-minute duration for audit purposes are likely to be governed by administrative guidance issued by the agency that implements the Act. The Determination does not supply that guidance; it creates the legal basis on which such administrative materials will be developed and applied.

Regulatory and professional regimes. The Determination's clinical description and minimum duration do not displace clinician professional regulation or standards. Professional standards, codes and privacy obligations remain in force and interact with the Determination insofar as clinicians' record-keeping and patient-consent obligations must satisfy regulatory requirements alongside the Determination's requirements.

No express interaction with state health laws. The Determination refers to fees specified "in relation to each State" (s 5 and Schedule), but it does not purport to regulate state health system funding or licencing. The primary statutory interaction is with the federal Health Insurance Act framework and the National Health Act 1953.

Practical consequence. Users of the Determination must therefore treat it as a statutory specification that plugs into the broader Health Insurance Act regime. The precise legal obligations placed on providers and the entitlement of patients will be determined by the interplay between the Determination, the general medical services table clauses it imports, and the other provisions of the Act and National Health Act as they stand over the Determination's operative period.

The instrument as provided is the text "as originally made" with a commencement table that the instrument itself observes will not be updated for later amendments (s 2 Commencement note). The Determination contains two temporal markers of note that form its immediate amendment and lifecycle history.

Original making and commencement. The instrument is executed under the authority of subsection 3C(1) of the Health Insurance Act 1973 (s 3). It contains a commencement table showing that "the whole of this instrument" commences on 1 July 2025 (s 2 Commencement table). The instrument therefore takes effect in full on that date.

Rebuttable instruction about future amendments. Section 4 contains an instruction that references to provisions of the Act or the National Health Act or regulations are references to those provisions "as in force from time to time." That wording has an operational effect akin to an amendment-resilience clause: subsequent changes to those Acts or regulations will automatically be incorporated into the interpretation and operation of this Determination, without the Determination itself needing amendment. Practically, this means the Determination's operation will reflect the statutory environment in which it exists at any given point during its operative period.

Expiry and repeal date. The Determination is expressly repealed at the end of 30 June 2027 (s 8 Repeal). That repeal date was set at the time of the instrument's making and therefore forms a scheduled termination of the Determination's legal operation unless, prior to that time, a further instrument is made to amend, extend or replace it.

No listed prior amendments in the instrument. The Determination contains no entries in its Schedule or text indicating that it amends existing instruments beyond its own Schedule items; s 9 explains the mechanism for amending instruments specified in a Schedule, but Schedule 1 here lists relevant services rather than identifying other instruments for amendment or repeal. The instrument's commencement note adds that the table relates only to the provisions "as originally made" and will not be amended to deal with later amendments of the instrument, which indicates that the printed instrument remains a record of the original text.

Practical implication for subsequent changes. Any legislative amendments to the Health Insurance Act or changes to the general medical services table that occur between 1 July 2025 and 30 June 2027 will affect how the Determination operates because of s 4. If policy-makers want to extend, replace or revise the items after 30 June 2027, they must make a subsequent Determination or amend the statutory tables as appropriate.

No amendment history entries to report. At present there are no earlier versions, amendments or revocations recorded within this instrument other than the scheduled repeal date. For practical purposes, users should treat the instrument as a time-limited measure whose operative text is the original text deposited with the commencement date and the repeal date.

The Determination contains no references to litigation, and the instrument as given does not record any case law or disputes arising from its operation. The text does not cite, rely upon or incorporate judicial decisions. There is therefore no internal litigation history within the Determination to report.

Potential areas for future litigation or review. While there is no existing litigation history, the Determination creates a small number of plausible interpretive issues that could give rise to administrative review or litigation under the Act or related regulations. The Determination itself identifies several cross-references to external provisions and definitions and leaves interpretive work to be done outside its four corners. Those areas of potential dispute are identified below in concrete terms grounded in the Determination:

• Meaning of "either of these services within the preceding 12 months" (s 7). The phrase requires interpretation about whether the 12-month clock runs from the date of a prior exam, the date of a claim, or another operational date. The Determination does not specify the triggering date beyond "from the date of receiving either of these services", so a dispute could arise as to whether a partial attendance or a different but related item should be treated as breaking the 12-month period.

• Classification of practitioner descriptors. The Schedule uses the terms "general practitioner" and "prescribed medical practitioner". The Determination notes that some key terms are defined in subsection 3(1) of the Act (s 4). Disputes could arise over whether a particular clinician, such as a specialist or an advanced-practice clinician, falls within the meaning of "prescribed medical practitioner" or whether a nurse practitioner may claim these items. The Determination leaves that question to be resolved by reference to the Act's definitions.

• Application and scope of clauses 2.15.1 and 2.15.14. Section 6 imports those clause numbers into the Determination but does not reproduce their text. If those clauses contain requirements that are ambiguous or onerous, parties may seek review or judicial interpretation of their application to items 695 and 19000.

• Documentation requirements and proof of 20-minute attendance. Because the Schedule sets a minimum duration of 20 minutes, disputes could arise about what constitutes sufficient evidence of time spent or whether the clinical content recorded meets the item description. The Determination does not specify documentary forms.

• Interaction with other items or concurrent claims. Practitioners and auditors may have differing views about whether other items claimed in the same attendance are permissible, or about aggregation rules under the general medical services table provisions. The Determination does not resolve those questions directly.

Administrative review and statutory remedies. Any disputes about claims, repayments or penalties will be resolved through the statutory claim review, recovery and penalty processes established in the Health Insurance Act and the administrative mechanisms of the relevant agency. The Determination does not create or modify those review rights.

Current absence of precedent. Because the Determination is newly created and time-limited, at the current moment there is no domestic judicial precedent interpreting its provisions. Advisers should therefore monitor administrative guidance and any early audit decisions or tribunal determinations that might clarify the operation of the 12-month rule, practitioner classifications, and the imported clause requirements.

The Determination's text contains several discrete features likely to cause operational errors if ignored. The following "gotchas" are concrete traps for clinicians, billers and administrators to watch for, each tied to a specific provision of the instrument.

1. 12-month frequency restriction scope (s 7). The service applies only if the patient "has not received either of these services within the preceding 12 months from the date of receiving either of these services." The language refers to "either of these services", meaning the two items in Schedule 1. Misreading this could lead to double claims within 12 months. Practices must check past claims histories for both item numbers 695 and 19000 before submitting a claim. The Determination does not define whether partial services, aborted consultations or telehealth variants count as "receiving" the service; this ambiguity gives rise to audit risk.

2. Minimum duration requirement , proof and aggregation (Schedule 1). Both items require an attendance of "at least 20 minutes." Failure to meet or to document a 20-minute face-to-face or equivalent attendance will expose the claim to rejection or recovery. The Determination does not set out acceptable evidence of time spent; thus, practices must maintain contemporaneous records showing date and duration. There is a risk of inadvertent under-documentation where practices use templated notes or where a consultation runs short of 20 minutes but contains the listed elements.

3. "Including, but not limited to" list versus mandatory elements (Schedule 1). The Schedule lists several elements using "including, but not limited to", which suggests the list is non-exhaustive. However the item description sets out minimum expectations; an audit could test whether the central listed elements were present. Practitioners should ensure notes demonstrate the substance of the listed activities rather than relying on boilerplate phrases.

4. Practitioner classification and correct item choice (Schedule 1 and s 4). Different fees attach to item 695 (general practitioner $101.90) and item 19000 (prescribed medical practitioner $81.50). Misclassifying the clinician or using the wrong item number will produce incorrect payments and potential recovery. The Determination refers to definitions in subsection 3(1) of the Act for certain terms; practices must consult the Act to ensure correct item selection, including what counts as a "prescribed medical practitioner".

5. Imported clause requirements (s 6). Section 6 imports clause 2.15.1 and clause 2.15.14 to apply to these items as if they were specified in those subclauses. Those clauses may contain additional requirements such as practitioner eligibility, patient consents, or exclusive circumstances for claiming. Failure to check those clause texts will leave claimants exposed to compliance pitfalls.

6. Two-year time limit and transition risk (s 2 and s 8). The Determination expires on 30 June 2027. Where a clinician provides the assessment shortly before the repeal date but billing or eligibility rules change, practices should be careful about retrospective claims or extended eligibility. There is a risk that administrative systems will not be updated in time for commencement or repeal, generating errors.

7. Interaction with other funding streams and tests. The Schedule suggests clinicians consider cervical screening, mammography and bone densitometry as clinically indicated, but the Determination does not address payment or referral rules for those diagnostic services. Practices may incorrectly assume that the item payment covers ancillary tests or that diagnostic services will be funded in a linked way; they will not be unless separately provided for under the relevant diagnostic funding schemes.

8. State fee language may be misinterpreted (s 5). Section 5 requires the item to be treated as if it specified a fee in relation to each State, and the Schedule shows one fee per item. Practices should not infer state-by-state variation from the Schedule in the absence of separate state schedules. The Determination fixes the fee amounts in the Schedule.

9. Failure to check changes "as in force from time to time" (s 4). Because references to other statutory provisions are to those "as in force from time to time", practitioners who rely on earlier versions of clauses or regulations risk non-compliance when the underlying statutory provisions are amended during the period the Determination is in force.

10. Administrative guidance lag. The Determination creates a legal basis for the items but does not contain the administrative guidance that agencies typically publish for claim submission and documentation. Practices that assume the existence of ready-made administrative procedures without waiting for official guidance risk mismatched processes and claim rejections.

Each of these points is grounded in specific text of the Determination: the 12-month rule and symptom list in s 7, the 20-minute minimum and listed elements in Schedule 1, the item numbers and fee figures in Schedule 1, the clause importing in s 6, the commencement and repeal dates in s 2 and s 8, and the "as in force from time to time" drafting in s 4. Addressing these "gotchas" requires attention to documentation, practitioner classification, claim histories and cross-checking of the general medical services table and relevant provisions of the Act.

The Determination provides a clear checklist of legal elements that practitioners and practices must satisfy to claim items 695 or 19000. Use the Determination text to operationalise compliance; the practical steps below map directly to the instrument's provisions.

1. Update billing systems and item mapping before 1 July 2025 (s 2). Ensure practice management and billing software include item 695 (GP) with fee $101.90 and item 19000 (prescribed medical practitioner) with fee $81.50 as of the Determination commencement date. Verify that claim submission pathways and item codes align with payer systems that apply the "relevant provisions."

2. Pre-screen patient eligibility using the clinical and frequency criteria (s 7). Before offering the assessment, confirm the patient is experiencing one or more symptoms of premature ovarian insufficiency, early menopause, perimenopause or menopause, or is undergoing treatment for those symptoms. Check claim history to ensure the patient has not "received either of these services" within the preceding 12 months. Maintain a process to search previous claims for both item numbers to satisfy the 12-month rule.

3. Meet and document the minimum attendance duration and content (Schedule 1). Ensure the professional attendance lasts at least 20 minutes. Document in clinical records the core elements specified in Schedule 1: history-taking to determine pre-/peri-/post-menopausal status and contraindications; a basic physical examination with blood pressure and recorded height and weight; initiation of investigations and referrals as clinically indicated; discussion of management options including risks and benefits; implementation of a patient-centred management plan; and provision of preventative health-care advice (physical activity, smoking cessation, alcohol consumption, nutrition and weight management). Use contemporaneous notes, timestamps, and templates that capture both duration and substance.

4. Choose the correct item number according to practitioner classification (Schedule 1 and s 4). Confirm whether the attending clinician qualifies as a "general practitioner" or a "prescribed medical practitioner" under the Act's definitions. Apply item 695 for general practitioners and item 19000 for prescribed medical practitioners. Where classification is uncertain, consult the Health Insurance Act definitions in subsection 3(1) and seek advice from the payer or legal counsel.

5. Check clause-level requirements in the general medical services table (s 6). Because s 6 applies clause 2.15.1 and clause 2.15.14 to these items, retrieve the current texts of those clauses in the general medical services table and ensure any procedural, documentation or practitioner eligibility requirements they impose are satisfied. If those clauses include conditions about where, by whom or how items may be claimed, incorporate those rules into practice processes.

6. Record referrals and investigations triggered by the assessment. If the clinical assessment initiates referrals or tests such as cervical screening, mammography or bone densitometry, document the indication and the referral. Do not assume that the assessment item covers the costs or claimability of the diagnostic tests; those are governed under separate items and schemes.

7. Prepare for audits and enquiries. Maintain a robust, dated clinical record showing time in attendance, the components addressed and any decisions or management plans formed. Because the Schedule specifies clinical elements and a time minimum, auditors will seek proof. Keep records in line with professional regulatory obligations and data retention policies.

8. Monitor legislative and regulatory changes (s 4). Because the Determination references provisions "as in force from time to time", maintain a process for checking amendments to the Health Insurance Act, the general medical services table, and relevant regulations during the Determination's operative period. Update practice protocols to reflect any changes that affect claim eligibility or documentation.

9. Implement a pre-claim checklist. Before lodging a claim, confirm: (a) patient meets symptom/treatment and 12-month criteria; (b) the attendance lasted at least 20 minutes; (c) records demonstrate the Schedule-listed elements; (d) correct item number used; (e) relevant clauses 2.15.1 and 2.15.14 requirements are observed; and (f) the claim date falls between 1 July 2025 and 30 June 2027.

10. Train clinicians and administrative staff on the Determination's specifics. Ensure clinical staff understand the 20-minute minimum and the content expectations. Ensure administrative staff can check previous claim histories and match staff classifications to the correct item numbers.

11. Seek clarification where ambiguous. Where the Determination does not specify a detail critical to claims practice (for example, the exact mechanics for determining when the 12-month period starts, or what evidence satisfies the minimum duration), seek authoritative administrative guidance from the payer or legal advice. Do not rely on assumptions in place of formal guidance, as the Determination leaves such details outside its text.

12. Prepare for the Determination's repeal date (s 8). If a practice establishes workflows and informed-consent processes linked to the existence of these items, plan for the scheduled end of the Determination on 30 June 2027. Track whether an extension or replacement is announced and plan communications to patients about any change in claimability or fees.

Following these steps, grounded in the instrument's text (notably s 5, s 6, s 7, Schedule 1, s 2 and s 8), will materially reduce the risk of rejected claims, recoveries or audit findings, and ensure that clinical practice and billing practices align with the Determination during its operative window.